The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Open accessAbstract
OBJECTIVE: Assess Aβ deposition longitudinally and explore its relationship with cognition and disease progression. METHODS: Clinical follow-up was obtained 20 ± 3 months after [¹¹C]Pittsburgh compound B (PiB)-positron emission tomography in 206 subjects: 35 with dementia of the Alzheimer type (DAT), 65 with mild cognitive impairment (MCI), and 106 age-matched healthy controls (HCs). A second PiB scan was obtained at follow-up in 185 subjects and a third scan after 3 years in 57. RESULTS: At baseline, 97% of DAT, 69% of MCI, and 31% of HC subjects showed high PiB retention. At 20-month follow-up, small but significant increases in PiB standardized uptake value ratios were observed in the DAT and MCI groups, and in HCs with high PiB retention at baseline (5.7%, 2.1%, and 1.5%, respectively). Increases were associated with the number of apolipoprotein E ε4 alleles. There was a weak correlation between PiB increases and decline in cognition when all groups were combined. Progression to DAT occurred in 67% of MCI with high PiB versus 5% of those with low PiB, but 20% of the low PiB MCI subjects progressed to other dementias. Of the high PiB HCs, 16% developed MCI or DAT by 20 months and 25% by 3 years. One low PiB HC developed MCI. INTERPRETATION: Aβ deposition increases slowly from cognitive normality to moderate severity DAT. Extensive Aβ deposition precedes cognitive impairment, and is associated with ApoE genotype and a higher risk of cognitive decline in HCs and progression from MCI to DAT over 1 to 2 years. However, cognitive decline is only weakly related to change in Aβ burden, suggesting that downstream factors have a more direct effect on symptom progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that progression of biomarker measures is also a continuous process that begins before symptoms [9–14]”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous studies have shown that CU individuals with abnormal amyloid biomarkers have more rapid progression of atrophy, hypometabolism, and clinical/cognitive decline than individuals without biomarker evidence of Aβ deposition [13,33,80,93–99]”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ε4 allele increased brain amyloid burden in a dose-dependent manner in normal elderly individuals and in mild cognitive impairment patients [93,94].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [94]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a study characterizing sporadic AD, for instance, Villemagne et al. used Pittsburgh compound B (PiB) positron emission tomography (PET) to show that 31% of healthy control subjects had high PiB retention indicating Aß deposition and of these, 25% developed mild cognitive impairment or AD by 3 years (Villemagne et al., 2011).”
From Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model (2022) · cites this paper as Villemagne et al., 2011
In the citing paper
“Previous longitudinal studies have either failed to detect an early increase in regional Aβ deposition16 or identified a rather large early stage Aβ region including the posterior temporal, inferior parietal, posterior cingulate, precuneus, and occipital areas4.”
From Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Self-citationVitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Design and construction of a realistic digital brain phantom
Collins, D. L., Zijdenbos, A. P., Kollokian, V., Sled, J. G., Kabani, N. J., Holmes, C. J., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.712135 · Cited by 1,825
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Self-citationJack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Cited by
Sorted by citations
Items 401–500 of 836
Brain Aging and Late-Onset Alzheimer’s Disease: A Matter of Increased Amyloid or Reduced Energy?
Mecocci, P., Baroni, M., Senin, U., & Boccardi, V. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179903 · Cited by 30
Jeong, S. H., Kim, H. R., Kim, J., Kim, H., Hong, N., Jung, J. H., Baik, K., Cho, H., Lyoo, C. H., Ye, B. S., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012534 · Cited by 32
Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment
Stevens, D. A., Workman, C. I., Kuwabara, H., Butters, M. A., Savonenko, A. V., Nassery, N., Gould, N. F., Kraut, M. A., Joo, J. H., Kilgore, J. J., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac016 · Cited by 32
1 H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
Nedelská, Z., Przybelski, S. A., Lesnick, T. G., Schwarz, C. G., Lowe, V. J., Machulda, M. M., Kremers, W. K., Mielke, M. M., Roberts, R. O., Boeve, B. F., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004421 · Cited by 29
Adamczuk, K., Weer, A. D., Nelissen, N., Dupont, P. J., Sunaert, S. G., Bettens, K., Sleegers, K., Broeckhoven, C. V., Laere, K. V., & Vandenberghe, R. R. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu286 · Cited by 32
Furumoto, S., Okamura, N., Furukawa, K., Tashiro, M., Ishikawa, Y., Sugi, K., Tomita, N., Waragai, M., Harada, R., Tago, T., et al. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0608-5 · Cited by 28
Yotter, R. A., Doshi, J. J., Clark, V., Sojkova, J., Zhou, Y., Wong, D. F., Ferrucci, L., Resnick, S. M., & Davatzikos, C. A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.030 · Cited by 29
Voyle, N., Kim, M., Proitsi, P., Ashton, N. J., Baird, A. L., Bazenet, C. E., Hye, A., Westwood, S., Chung, R., Ward, M. A., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.205 · Cited by 28
Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer’s Disease
Robinson, R. A. S., Amin, B., & Guest, P. C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-52479-5_2 · Cited by 29
Tort‐Merino, A., Valech, N., Peñaloza, C., Grönholm-Nyman, P., León, M., Olives, J., Estanga, A., Ecay‐Torres, M., Fortea, J., Martínez‐Lage, P., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161173 · Cited by 33
Joint associations of β-amyloidosis and cortical thickness with cognition
Knopman, D. S., Lundt, E. S., Therneau, T. M., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., Machulda, M. M., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.017 · Cited by 29
Cox, C. G., Mary M. Ryan, B. A., Gillen, D. L., & Grill, J. D. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.10.016 · Cited by 28
on behalf of the Cognitive Function and Ageing Neuropathology Study Group, Wharton, S. B., Wang, D. Y. Q., Parikh, C. R., Matthews, F. E., Brayne, C., & Ince, P. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0858-4 · Cited by 32
Amyloid, tau and risk of Alzheimer’s disease: a Mendelian randomization study
Yeung, C. H. C., Lau, K. W. D., Yeung, S. L. A., & Schooling, C. M. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00683-8 · Cited by 28
Callens, M., Loncke, J., & Bultynck, G. (2022) · Cells · doi:10.3390/cells11121963 · Cited by 30
Molecular imaging in the diagnosis of Alzheimer's disease and related disorders
Koric, L., Guedj, É., Habert, M., Semah, F., Branger, P., Payoux, P., & Jeune, F. L. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.10.009 · Cited by 29
Biomarker-based signature of alzheimer's disease in pre-MCI individuals
Chipi, E., Salvadori, N., Farotti, L., & Parnetti, L. (2019) · Brain Sciences · doi:10.3390/brainsci9090213 · Cited by 27
Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective
Scarano, N., Musumeci, F., Casini, B., Brullo, C., D’Ursi, P., Fossa, P., Schenone, S., & Cichero, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146980 · Cited by 32
Arbizu, J., García‐Ribas, G., Carrió, I., Garrastachu, P., Martínez‐Lage, P., & Molinuevo, J. L. (2015) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2015.03.002 · Cited by 30
Pluta, R. M., & Ułamek-Kozioł, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_4 · Cited by 51
Amyloid imaging in prodromal Alzheimer's disease
Ossenkoppele, R., van Berckel, B. N. M., & Prins, N. D. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt88 · Cited by 27
The Olfactory Trail of Neurodegenerative Diseases
Franco, R., Garrigós, C., & Lillo, J. (2024) · Cells · doi:10.3390/cells13070615 · Cited by 26
Steininger, S. C., Liu, X., Gietl, A. F., Wyss, M., Schreiner, S. J., Gruber, E., Treyer, V., Kälin, A. M., Leh, S. E., Buck, A., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00052 · Cited by 27
Lin, S.-Y., Lin, K., Lin, P.-C., Huang, C.-C., Chang, C., Lee, Y., Hsiao, I., Yen, T., Huang, W.-S., Yang, B., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0566-0 · Cited by 26
Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
Sordo, L., Martini, A. C., Houston, E. F., Head, E., & Gunn-Moore, D. A. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.684607 · Cited by 26
Panmak, P., Nopparat, C., Permpoonpattana, K., Namyen, J., & Govitrapong, P. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105121 · Cited by 26
Recent Advances in Imaging Alzheimer's Disease
Braskie, M. N., Toga, A. W., & Thompson, P. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129016 · Cited by 26
Amyloid-β Load Predicts Medial Temporal Lobe Dysfunction in Alzheimer Dementia
Frings, L., Spehl, T. S., Weber, W., Hüll, M., & Meyer, P. T. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120378 · Cited by 25
Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease
Butcher, N. J., Horne, M. K., Mellick, G. D., Fowler, C. J., Masters, C. L., & Minchin, R. F. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.4 · Cited by 26
Self-citationA guide to using functional magnetic resonance imaging to study Alzheimer's disease in animal models
Asaad, M., & Lee, J. H. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031724 · Cited by 26
Wong, S., Strudwick, J., Devenney, E. M., Hodges, J. R., Piguet, O., & Kumfor, F. (2019) · Neurocase · doi:10.1080/13554794.2019.1609523 · Cited by 25
Gagliardi, G. P., for the INSIGHT-preAD study group, Epelbaum, S., Houot, M., Bakardjian, H., Boukadida, L., Revillon, M., Dubois, B., Barba, G. D., & Corte, V. L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180966 · Cited by 25
The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates
Creekmore, B. C., Chang, Y., & Lee, E. B. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab039 · Cited by 28
The Transcranial Light Therapy Improves Synaptic Plasticity in the Alzheimer’s Disease Mouse Model
Buendía, D., Guncay, T., Oyanedel, M., Lemus, M., Weinstein, A., Ardiles, Á. O., Marcos, J. L., Fernandes, A. B., Zângaro, R. A., & Muñoz, P. (2022) · Brain Sciences · doi:10.3390/brainsci12101272 · Cited by 26
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
Ayyubova, G. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230303114425 · Cited by 23
André, C., Kuhn, E., Réhel, S., Ourry, V., Demeilliez-Servouin, S., Palix, C., Felisatti, F., Champetier, P., Dautricourt, S., Yushkevich, P., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207421 · Cited by 21
Self-citationVolloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 29
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
Barrera-Ocampo, A. A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.034 · Cited by 30
Lim, Y. Y., Rainey‐Smith, S. R., Lim, Y. P., Laws, S. M., Gupta, V. B., Porter, T., Bourgeat, P., Ames, D. J., Fowler, C. J., Salvado, O., et al. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217001284 · Cited by 24
Self-citationMaggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Jung, Y., Whitwell, J. L., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Jack, C. R., Lowe, V. J., & Josephs, K. A. (2015) · European Journal of Neurology · doi:10.1111/ene.12761 · Cited by 27
Adamczuk, K., Weer, A. D., Nelissen, N., Dupont, P. J., Sunaert, S. G., Bettens, K., Sleegers, K., Broeckhoven, C. V., Laere, K. V., & Vandenberghe, R. R. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw117 · Cited by 24
Freeze, W. M., on behalf of the LeARN project, Jacobs, H. I. L., Gronenschild, E. H. B. M., Jansen, J. F. A., Burgmans, S., Aalten, P., Clerx, L., Vos, S. J. B., van Buchem, M. A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160474 · Cited by 26
Rhabdomyolysis with different etiologies in childhood
Alaygut, D., Bayram, M. T., Kasap, B., Soylu, A., Turkmen, M. A., & Kavukçu, S. (2017) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v6.i4.161 · Cited by 24
Molecular Imaging of Alzheimer Disease Pathology
Kantarci, K. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3847 · Cited by 24
Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET
Guo, T., Brendel, M., Grimmer, T., Rominger, A., & Yakushev, I. Y. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.176115 · Cited by 24
Porter, T., Villemagne, V. L., Savage, G. R., Milicic, L., Lim, Y. Y., Maruff, P. T., Masters, C. L., Ames, D. J., Bush, A. I., Martins, R. N., et al. (2018) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2018.03.001 · Cited by 24
Self-citationCuriel, R. E., Loewenstein, D., Rosselli, M., Peñate, A., Greig‐Custo, M. T., Bauer, R. M., Guinjoan, S. M., Hanson, K., Li, C., Lizarraga, G., et al. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666180427122746 · Cited by 24
Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
Kim, S. E., Lee, B., Park, S., Cho, S. H., Kim, S. J., Kim, Y., Jang, H., Jeong, J. H., Yoon, S. J., Park, K. W., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0577-x · Cited by 23
Preventing cognitive decline in preclinical Alzheimer's disease
Riedel, W. J. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.10.002 · Cited by 22
Amyloid burden and white matter hyperintensities mediate age-related cognitive differences
Dupont, P. S., Bocti, C., Joannette, M., Lavallée, M. M., Nikelski, J., Vallet, G. T., Chertkow, H., & Joubert, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.025 · Cited by 25
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia
Eisenmenger, L. B., Huo, E. J., Hoffman, J. M., Minoshima, S., Matesan, M. C., Lewis, D. H., Lopresti, B. J., Mathis, C. A., Okonkwo, D. O., & Mountz, J. M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.09.003 · Cited by 21
Self-citationHatashita, S., Wakebe, D., Kikuchi, Y., & Ichijo, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00251 · Cited by 22
Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage
Li, T.-R., Yang, Q. Z., Hu, X., & Han, Y. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524153901 · Cited by 23
The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 22
APOE and vascular disease: Sequencing and genotyping in general population cohorts
Rasmussen, K. L., Luo, J., Nordestgaard, B. G., Tybjærg-Hansen, A., & Frikke-Schmidt, R. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117218 · Cited by 22
Grimmer, T., Goldhardt, O., Guo, L., Yousefi, B. H., Förster, S., Drzezga, A. E., Sorg, C., Alexopoulos, P., Förstl, H., Kurz, A., et al. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.01.016 · Cited by 23
P ittsburgh compound B retention and progression of cognitive status – a meta‐analysis
Chen, X., Li, M., Wang, S., Zhu, H., Xiong, Y., & Liu, X. (2014) · European Journal of Neurology · doi:10.1111/ene.12398 · Cited by 26
Knockout of 5‐lipoxygenase prevents dexamethasone‐induced tau pathology in 3xTg mice
Joshi, Y. B., Chu, J., & Praticò, D. (2013) · Aging Cell · doi:10.1111/acel.12096 · Cited by 22
Future Directions in Imaging Neurodegeneration
Masdeu, J. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0718-1 · Cited by 22
Hessen, E., Nordlund, A., Stålhammar, J., Eckerström, M., Bjerke, M., Eckerström, C., Göthlin, M., Fladby, T., Reinvang, I., & Wallin, A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150109 · Cited by 21
Wolf, D. G. F., Initiative, A. D. N., Fischer, F. U., & Fellgiebel, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190370 · Cited by 21
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer’s disease
Lozupone, M., Berardino, G., Mollica, A., Sardone, R., Dibello, V., Zupo, R., Lampignano, L., Castellana, F., Bortone, I., Stallone, R., et al. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2095261 · Cited by 22
Berman, S. E., Clark, L. R., Rivera‐Rivera, L. A., Norton, D., Racine, A. M., Rowley, H. A., Bendlin, B. B., Blennow, K., Zetterberg, H., Carlsson, C. M., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170402 · Cited by 21
Leuzy, A., Rodriguez‐Vieitez, E., Saint‐Aubert, L., Chiotis, K., Almkvist, O., Savitcheva, I., Jonasson, M., Lubberink, M., Wall, A. E., Antoni, G., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.11.008 · Cited by 21
Golan, S., Boccara, E., Ravona‐Springer, R., Inbar, Y., Zelicha, H., Livny, A., Bendlin, B. B., Lesman‐Segev, O. H., Yore, I., Heymann, A. D., et al. (2024) · Obesity · doi:10.1002/oby.24004 · Cited by 21
[18F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment
Jeong, H.-J., Lee, H., Lee, S., Seo, S., Park, K. H., Lee, Y., Shin, D. J., Kang, J. M., Yeon, B. K., Kang, S., et al. (2020) · Journal of Clinical Neurology · doi:10.3988/jcn.2020.16.2.202 · Cited by 20
Self-citationPET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 20
Initiative, A. D. N., Sörensen, A., Blazhenets, G., Schiller, F., Meyer, P. T., & Frings, L. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00721-3 · Cited by 20
Pedrini, S., Doecke, J. D., Hone, E., Wang, P., Thota, R. N., Bush, A. I., Rowe, C. C., Doré, V., Villemagne, V. L., Ames, D. J., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15681 · Cited by 20
Self-citationRamakrishnan, V., Friedrich, C. M., Witt, C. M., Sheehan, R., Pryor, M. M., Atwal, J. K., Wildsmith, K. R., Kudrycki, K., Lee, S., Mazer, N. A., et al. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12876 · Cited by 21
Implication of the cooking oil-peroxidation product “hydroxynonenal” for Alzheimer’s disease
Yamashima, T., Seike, T., Mochly‐Rosen, D., Chen, C., Kikuchi, M., & Mizukoshi, E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1211141 · Cited by 20
Assessing Mild Cognitive Impairment with Amyloid and Dopamine Terminal Molecular Imaging
Albin, R. L., Burke, J. F., Koeppe, R. A., Giordani, B., Gilman, S., & Frey, K. A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.112599 · Cited by 20
Accumulation of amyloid-β in the cerebellar cortex of essential tremor patients
Béliveau, É., Tremblay, C., Aubry-Lafontaine, É., Paris‐Robidas, S., Delay, C., Robinson, C. A., Ferguson, L., Rajput, A. H., Rajput, A. H., & Calon, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.016 · Cited by 22
Brain Molecular Connectivity in Neurodegenerative Conditions
Carli, G., Tondo, G., Boccalini, C., & Perani, D. (2021) · Brain Sciences · doi:10.3390/brainsci11040433 · Cited by 20
Deconvolution-based partial volume correction of PET images with parallel level set regularization
Zhu, Y., Bilgel, M., Gao, Y., ROUSSET, O. G., Resnick, S. M., Wong, D. F., & Rahmim, A. (2021) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ac0d8f · Cited by 17
Siejka, T. P., Srikanth, V. K., Hubbard, R. E., Moran, C., Beare, R. J., WOOD, A. G., Collyer, T. A., Gujjari, S., Phan, T. G., & Callisaya, M. L. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac078 · Cited by 19
Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex
Choo, X. Y., McInnes, L. E., Grubman, A., Wasielewska, J. M., Belaya, I., Burrows, E. L., Quek, H., Cañas-Martín, J., Loppi, S. H., Sorvari, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810722 · Cited by 19
Parent, C., Rousseau, L., Predovan, D., Duchesne, S., & Hudon, C. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100074 · Cited by 21
APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
Balu, D., Valencia‐Olvera, A. C., Islam, Z., Mielczarek, C., Hansen, A. L., Ramos, T. M. P., York, J. M., LaDu, M. J., & Tai, L. M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1279343 · Cited by 20
Pérez‐Grijalba, V., Pesini, P., Monleón, I., Boada, M., Tárraga, L., Ruiz, A., Martínez‐Lage, P., José, I. S., & Sarasa, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121744 · Cited by 20
Grill, J. D., Bateman, R. J., Buckles, V., Oliver, A., Morris, J. C., Masters, C. L., Klunk, W. E., Ringman, J. M., & for the Dominantly Inherited Alzheimer’s Network (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0135-0 · Cited by 18
Self-citationThe Relationship between Amyloid Deposition, Neurodegeneration, and Cognitive Decline in Dementia
Vandenberghe, R. R. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0498-9 · Cited by 21
Kormas, C., Megalokonomou, A., Zalonis, I., Evdokimidis, I., Kapaki, E. N., & Potagas, C. M. (2018) · The Clinical Neuropsychologist · doi:10.1080/13854046.2018.1495270 · Cited by 19
Chiaravalloti, A., Barbagallo, G., Martorana, A., Castellano, A. E., Ursini, F., & Schillaci, O. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04379-4 · Cited by 19
Huang, W., Bartosch, A. M. W., Xiao, H., Maji, S., Youth, E. H. H., Flowers, X. E., Leskinen, S., Tomljanovic, Z., Iodice, G. M., Boyett, D. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25902-y · Cited by 17
Lim, Y. Y., Kong, J., Maruff, P. T., Jaeger, J., Huang, E., & Ratti, E. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.64 · Cited by 18
Tomassen, J., den Braber, A., van der Landen, S. M., Konijnenberg, E., Teunissen, C. E., Vermunt, L., de Geus, E. J. C., Boomsma, D. I., Scheltens, P., Tijms, B. M., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12346 · Cited by 16
Luckett, E. S., Abakkouy, Y., Reinartz, M., Adamczuk, K., Schaeverbeke, J. M., Verstockt, S., Meyer, S. D., Laere, K. V., Dupont, P. J., Cleynen, I., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01079-4 · Cited by 18
Kanel, P., Carli, G., Vangel, R., Roytman, S., & Bohnen, N. I. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1293847 · Cited by 18
Chattopadhyay, T., Ozarkar, S. S., Buwa, K., Joshy, N. A., Komandur, D., Naik, J., Thomopoulos, S. I., Steeg, G. V., Ambite, J. L., & Thompson, P. M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1387196 · Cited by 21
Molecular Neuroimaging in Alzheimer's Disease
Matsuda, H., & Imabayashi, E. (2011) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.005 · Cited by 21
Frisoni, G. B., Perani, D., Bastianello, S., Bernardi, G., Porteri, C., Boccardi, M., Cappa, S. F., Trabucchi, M., & Padovani, A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.033 · Cited by 18
Hunter, J. M., Bowers, W. J., Maarouf, C. L., Mastrangelo, M. A., Daugs, I. D., Kokjohn, T. A., Kalback, W. M., Luehrs, D. C., Valla, J., Beach, T. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110608 · Cited by 18
Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model
Reinitz, F., Chen, E. Y., Nicolis di Robilant, B., Chuluun, B., Antony, J., Jones, R. C., Gubbi, N., Lee, K., Ho, W. H. D., Kolluru, S. S., et al. (2022) · eLife · doi:10.7554/elife.66037 · Cited by 18
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort
Younes, K., Johns, E., Young, C. B., Kennedy, G., Mukherjee, S., Vossler, H. A., Winer, J. R., Cody, K. A., Henderson, V. W., Poston, K. L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70075 · Cited by 18
Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360
Rueeger, H., Lueoend, R. M., Machauer, R., Veenstra, S. J., Holzer, P., Hurth, K., Voegtle, M., Frederiksen, M. U., Rondeau, J., Tintelnot‐Blomley, M., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02143 · Cited by 17
Biomarkers and Tools for Predicting Alzheimer's Disease in the Preclinical Stage
Li, T., Yang, Q. Z., Hu, X., & Han, Y. (2022) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 17
Gender-specific relationship between thigh muscle and fat mass and brain amyloid-β positivity
Kang, S. H., Lee, K. H., Chang, Y., Choe, Y. S., Kim, J. P., Jang, H., Shin, H. Y., Kim, H. J., Koh, S., Na, D. L., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01086-5 · Cited by 19
Frequency-Dependent Microstate Characteristics for Mild Cognitive Impairment in Parkinson’s Disease
Liu, C., Jiang, Z., Liu, S., Chu, C., Wang, J., Liu, W., Sun, Y., Dong, M., Shi, Q., Huang, P., et al. (2023) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2023.3324343 · Cited by 18
Metadata
- Authors
- Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., Martins, R., O'Keefe, G., Mathis, C. A., Klunk, W. E., Ames, D., Masters, C. L., & Rowe, C. C.
- Affiliations
- Mental Health Research Institute (AU)
- Austin Health (AU)
- Commonwealth Scientific and Industrial Research Organisation (AU)
- Australian e-Health Research Centre (AU)
- Edith Cowan University (AU)
- University of Pittsburgh (US)
- National Ageing Research Institute (AU)
- The University of Melbourne (AU)
- Corresponding author
- Villemagne, Victor L.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 69
- Issue
- 1
- Pages
- 181-192
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC3045039
- OpenAlex
- W2051489981
- Cited by
- 833
- References
- 42
- Citations by year
- 2026: 28 · 2025: 32 · 2024: 26 · 2023: 51 · 2022: 42 · 2021: 44 · 2020: 57 · 2019: 60 · 2018: 57 · 2017: 57 · 2016: 60 · 2015: 61 · 2014: 68 · 2013: 86 · 2012: 71
- FWCI
- 57.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Edith Cowan University Research Online (Edith Cowan University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG025204, RF1AG025516, P50AG005133, R37AG025516)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- amyloid-beta deposition, Alzheimer's disease, mild cognitive impairment, Pittsburgh compound B PET, APOE ε4, cognitive decline, disease progression, aging
- MeSH terms
- Aged, Aging, Alzheimer Disease, Aniline Compounds, Brain, Cognition, Cognition Disorders, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Polymorphism, Genetic, Severity of Illness Index, Thiazoles, Amyloid beta-Peptides, Disease Progression, Positron-Emission Tomography, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
